( NYSE:AGN )

News from Allergan plc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

08:00 ET FDA Acceptance of Medicines360's Filing for supplemental New Drug Application for LILETTA® (levonorgestrel-releasing intrauterine system) 52 mg

Allergan plc, (NYSE: AGN) a leading global pharmaceutical company, and Medicines360, a global nonprofit women's health pharmaceutical company with...


Feb 16, 2018, 18:58 ET Allergan Presents Data at the 2018 American Academy of Dermatology (AAD) Annual Meeting in San Diego

Allergan plc (NYSE: AGN) today announced that its data will be featured during the 2018 American Academy of Dermatology (AAD) Annual Meeting in San...


Feb 09, 2018, 08:00 ET Allergan Declares First Quarter 2018 Cash Dividend of $0.72 Per Ordinary Share and Provides Annual General Meeting of Shareholders Updates

Allergan plc (NYSE: AGN) today announced its Board of Directors has declared a cash dividend of $0.72 per ordinary share for the first quarter of...


Feb 06, 2018, 07:00 ET Allergan Reports Solid Finish to 2017 with 12% Increase in Fourth Quarter GAAP Net Revenues to $4.3 Billion

Allergan plc (NYSE: AGN) today reported its fourth quarter and full-year 2017 continuing operations performance. Fourth Quarter and Full-Year 2017...


Feb 06, 2018, 06:45 ET Allergan Announces Positive Top Line Phase 3 Results for Ubrogepant - an Oral CGRP Receptor Antagonist for the Acute Treatment of Migraine

Allergan plc, (NYSE: AGN), a leading global pharmaceutical company today announced positive results from ACHIEVE I (UBR-MD-01), the first of two...


Feb 05, 2018, 07:51 ET Matthew M. Walsh Appointed Executive Vice President and Chief Financial Officer of Allergan plc

Allergan plc (NYSE: AGN) a leading global biopharmaceutical company, today announced that Matthew M. Walsh has been appointed Executive Vice...


Feb 01, 2018, 16:31 ET FDA Approves AVYCAZ® (ceftazidime and avibactam) for the Treatment of Patients with Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia

Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved...


Jan 31, 2018, 16:15 ET Allergan to Present at The Leerink Partners 7th Annual Global Healthcare Conference

Allergan plc (NYSE:AGN), a leading global biopharmaceutical company, today announced that Chief Commercial Officer William Meury and Chief...


Jan 31, 2018, 07:31 ET Allergan Introduces "Not Cool vs. Cool" Multi-Channel Campaign for CoolSculpting® and Professional Athlete Brand Ambassadors: Figure Skater Johnny Weir and Golfer Ian Poulter

Allergan plc (NYSE: AGN) today launches a new multi-channel direct-to-consumer campaign for CoolSculpting, titled "Not Cool vs. Cool," which...


Jan 08, 2018, 16:30 ET Allergan Provides 2018 Preliminary Financial Outlook for Select Income Statement Categories and Other Updates at 36th Annual J. P. Morgan Conference

Allergan plc (NYSE: AGN), a leading global pharmaceutical company, is providing its 2018 preliminary financial outlook and other financial updates...


Jan 08, 2018, 09:00 ET Allergan to Report Fourth Quarter and Full Year 2017 Earnings and Host Conference Call and Webcast

Allergan plc (NYSE: AGN) today announced it intends to release fourth quarter and full year 2017 financial results on Tuesday, February 6, 2018,...


Dec 26, 2017, 08:00 ET Allergan to Present at the 36th Annual J.P. Morgan Healthcare Conference

Allergan plc (NYSE: AGN), a leading global biopharmaceutical company, today announced that Chairman and CEO Brent Saunders will present at the 36th...


Dec 22, 2017, 14:45 ET Allergan Acknowledges Appeals Court Decision for COMBIGAN®

Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced that the United States Court of Appeals for the Federal Circuit...


Dec 20, 2017, 16:30 ET FDA Accepts New Drug Application For Seysara™ (Sarecycline) For The Treatment Of Moderate To Severe Acne

Allergan plc, (NYSE: AGN) a leading global pharmaceutical company, and Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a biopharmaceutical company...


Dec 18, 2017, 08:00 ET Allergan and Richter Announce Positive Topline Results from Phase 3 Study of Cariprazine for the Treatment of Bipolar I Depression

Allergan plc (NYSE: AGN), a leading global pharmaceutical company, and Gedeon Richter Plc., today announced positive topline results for a phase 3...


Dec 18, 2017, 07:05 ET Allergan Announces Promotion of Wayne Swanton to Executive Vice President, Global Operations

Allergan plc (NYSE: AGN) a leading global biopharmaceutical company, today announced that Wayne Swanton has been promoted to Executive Vice...


Dec 12, 2017, 08:51 ET Allergan Receives FDA Clearance For the CoolSculpting® Treatment To Improve Appearance Of Lax Tissue In The Double Chin

Allergan plc (NYSE: AGN) today announced that the CoolSculpting® treatment is the first and only non-surgical fat reduction technology to be...


Nov 29, 2017, 08:01 ET Allergan's Migraine Leadership Recognized with Enrico Greppi Award for Excellence in Headache Research

Allergan plc, (NYSE: AGN), a leading global pharmaceutical company, is pleased to announce that its manuscript, "Fluctuations in Episodic and...


Nov 22, 2017, 16:15 ET Allergan to Present at the 2017 Citi Global Healthcare Conference

Allergan plc (NYSE: AGN), a leading global biopharmaceutical company, today announced that Chief Commercial Officer William Meury will present at...


Nov 16, 2017, 08:00 ET Allergan to Present at the Evercore ISI 2017 Biopharma Catalyst/Deep Dive Conference

Allergan plc (NYSE: AGN), a leading global biopharmaceutical company, today announced that David Nicholson, Allergan's Chief Research and...


Nov 14, 2017, 08:00 ET Overactive Bladder Causes Significant Burden, Regardless of Age Amongst Adults

Allergan, Inc. (NYSE: AGN), in partnership with the National Association For Continence (NAFC), today announced the results of a new survey that...


Nov 13, 2017, 07:35 ET Allergan Receives FDA Approval For Use of VRAYLAR™ (cariprazine) in the Maintenance Treatment of Schizophrenia

Allergan plc (NYSE: AGN) today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA)...


Nov 08, 2017, 08:00 ET Allergan to Present Dynamic Eye Care Data at American Academy of Ophthalmology Meeting in New Orleans

Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced its data will be presented at the annual American Academy...


Nov 07, 2017, 07:00 ET Allergan to Present at Credit Suisse 26th Annual Healthcare Conference

Allergan plc (NYSE: AGN), a leading global biopharmaceutical company, today announced that William Meury, Allergan's Chief Commercial Officer, will...


Nov 01, 2017, 07:00 ET Allergan Reports Solid Top-Line Execution in Third Quarter 2017 with 11% Increase in GAAP Net Revenues to $4.03 Billion

Allergan plc (NYSE: AGN) today reported its third quarter 2017 continuing operations performance. Third Quarter 2017 Continuing Operations...